Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas

Histopathology

Volumn 56, Issue 3, 2010, Pages 364-371

  Mankey, Cohra C ^a   McHugh, Jonathan B ^a   Thomas, Dafydd G ^a   Lucas, David R ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Angiosarcoma; D2 40; Immunohistochemistry; Lymphangiosarcoma; Podoplanin; Prox 1; VEGFR 3

Indexed keywords

ANTIGEN; MONOCLONAL ANTIBODY D2-40; TUMOR MARKER; VASCULOTROPIN RECEPTOR 3;

ANGIOSARCOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER PATIENT; CELL AGGREGATION; CELL DIFFERENTIATION; CELL STRUCTURE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; ERYTHROCYTE; FACE TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; LYMPHANGIOSARCOMA; LYMPHEDEMA; PRIORITY JOURNAL; SCALP TUMOR; TISSUE MICROARRAY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CELL DIFFERENTIATION; ENDOTHELIUM, LYMPHATIC; FEMALE; HEMANGIOSARCOMA; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHANGIOSARCOMA; MALE; MIDDLE AGED; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 77449147745     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03484.x     Document Type: Article

References (21)

1. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy edema: a report of six cases in elephantiasis chirugica. Cancer 1948 1 64 81.
2. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors, 5th edn. Philadelphia : Mosby, 2008.
3. Fukunaga M. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours. Histopathology 2005 46 396 402.
4. Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer 1999 86 2406 2412.
5. Kahn HJ, Bailey D, Marks A. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas. Mod. Pathol. 2002 15 434 440.
6. Galambos C, Nodit L. Identification of lymphatic endothelium in pediatric vascular tumors and malformations. Pediatr. Dev. Pathol. 2005 8 181 189.
7. Reis RM, Reis-Filho JS, Longatto Filho A, Tomarev S, Silva P, Lopes JM. Differential Prox-1 and CD 31 expression in mucousae, cutaneous and soft tissue vascular lesions and tumors. Pathol. Res. Pract. 2005 201 771 776.
8. Xu H, Edwards JR, Espinosa O, Banerji S, Jackson DG, Athanasou NA. Expression of a lymphatic endothelial cell marker in benign and malignant vascular tumors. Hum. Pathol. 2004 35 857 861.
9. Arai E, Kuramochi A, Tsuchida T et al. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J. Cutan. Pathol. 2006 33 492 497.
10. Lymboussaki A, Partanen TA, Olofsson B et al. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Am. J. Pathol. 1998 153 395 403.
11. Folpe AL, Veikkola T, Valtola R, Weiss SW. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod. Pathol. 2000 13 180 185.
12. Debelenko LV, Perez-Atayde AR, Mulliken JB, Liang MG, Archibald TH, Kozakewich HP. D2-40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod. Pathol. 2005 18 1454 1460.
13. Jussila L, Valtola R, Partanen TA et al. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 1998 58 1599 1604.
14. Breiteneder-Geleff S, Soleiman A, Kowalski H et al. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am. J. Pathol. 1999 154 385 394.
15. Itakura E, Yamamoto H, Oda Y, Tsuneyoshi M. Detection and characterization of vascular endothelial growth factors and their receptors in a series of angiosarcomas. J. Surg. Oncol. 2008 97 74 81.
16. Makinen T, Norrmen C, Petrova TV. Molecular mechanisms of lymphatic vascular development. Cell. Mol. Life Sci. 2007 64 1915 1929.
17. Tammela T, Petrova TV, Alitalo K. Molecular lymphangiogenesis: new players. Trends Cell Biol. 2005 15 434 441.
18. Hancox JG, Yount LS, Eaton JS, Barnette DJ, Greenway HT Jr. Lymphangiosarcoma presenting as asymptomatic swelling of the cheek. J. Am. Acad. Dermatol. 2007 56 530 531.
19. Holden CA, Spaull J, Das AK, McKee PH, Jones EW. The histogenesis of angiosarcoma of the face and scalp: an immunohistochemical and ultrastructural study. Histopathology 1987 11 37 51.
20. Reed RJ, Palomeque FE, Hairston MA 3rd., Krementz ET. Lymphangiosarcomas of the scalp. Arch. Dermatol. 1966 94 396 402.
21. Sordillo PP, Chapman R, Hajdu SI, Magill GB, Golbey RB. Lymphangiosarcoma. Cancer 1981 48 1674 1679.